Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sequent Scientific has informed that it enclosed the Earnings Call Transcript pertaining to the Unaudited Financial Results of the Company for quarter and half year ended September 30, 2022. The same is also available on the Company’s website at SeQuentScientific-Earnings-08Nov2022.pdf.
The above information is a part of company’s filings submitted to BSE.